Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Cuzick

Showing results (261-270 of 367) with videos related to

Pageof 37
Sort By:
Obstetrics and Gynecology|November 9, 2016
Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations: Implications for Clinical GuidelinesJulia C Gage, William C Hunt, Mark Schiffman, et al.
NPJ Parkinson'S Disease|April 2, 2021
Improving estimation of Parkinson's disease risk-the enhanced PREDICT-PD algorithmJonathan P Bestwick, Stephen D Auger, Cristina Simonet, et al.
Journal of Medical Virology|August 13, 2011
Human papillomavirus genotype detection and viral load in paired genital and urine samples from both females and malesSara L Bissett, Rebecca Howell-Jones, Craig Swift, et al.
Lancet (London, England)|December 17, 2013
Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trialJack Cuzick, Ivana Sestak, John F Forbes, et al.
Journal of Medical Virology|June 1, 2010
Performance of the Abbott RealTime high-risk HPV test in women with abnormal cervical cytology smearsJack Cuzick, Laurence Ambroisine, Louise Cadman, et al.
The Lancet. Oncology|September 17, 2013
Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study populationDennis C Sgroi, Ivana Sestak, Jack Cuzick, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 6, 2011
Risk factors for high-risk human papillomavirus infection and cofactors for high-grade cervical disease in PeruMaribel Almonte, Catterina Ferreccio, Miguel Gonzales, et al.
Endocrine-Related Cancer|July 20, 2007
Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction modelRichard J Santen, Norman F Boyd, Rowan T Chlebowski, et al.
JAMA Oncology|September 30, 2016
Population-Based Incidence Rates of Cervical Intraepithelial Neoplasia in the Human Papillomavirus Vaccine EraVicki B Benard, Philip E Castle, Steven A Jenison, et al.
International Journal of Cancer|June 29, 2019
A case-control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic densityAdam R Brentnall, Elke M van Veen, Elaine F Harkness, et al.
Pageof 37

Showing results (261-270 of 367) with videos related to

Sort By:
Pageof 37
Obstetrics and Gynecology|November 9, 2016
Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations: Implications for Clinical GuidelinesJulia C Gage, William C Hunt, Mark Schiffman, et al.
NPJ Parkinson'S Disease|April 2, 2021
Improving estimation of Parkinson's disease risk-the enhanced PREDICT-PD algorithmJonathan P Bestwick, Stephen D Auger, Cristina Simonet, et al.
Journal of Medical Virology|August 13, 2011
Human papillomavirus genotype detection and viral load in paired genital and urine samples from both females and malesSara L Bissett, Rebecca Howell-Jones, Craig Swift, et al.
Lancet (London, England)|December 17, 2013
Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trialJack Cuzick, Ivana Sestak, John F Forbes, et al.
Journal of Medical Virology|June 1, 2010
Performance of the Abbott RealTime high-risk HPV test in women with abnormal cervical cytology smearsJack Cuzick, Laurence Ambroisine, Louise Cadman, et al.
The Lancet. Oncology|September 17, 2013
Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study populationDennis C Sgroi, Ivana Sestak, Jack Cuzick, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 6, 2011
Risk factors for high-risk human papillomavirus infection and cofactors for high-grade cervical disease in PeruMaribel Almonte, Catterina Ferreccio, Miguel Gonzales, et al.
Endocrine-Related Cancer|July 20, 2007
Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction modelRichard J Santen, Norman F Boyd, Rowan T Chlebowski, et al.
JAMA Oncology|September 30, 2016
Population-Based Incidence Rates of Cervical Intraepithelial Neoplasia in the Human Papillomavirus Vaccine EraVicki B Benard, Philip E Castle, Steven A Jenison, et al.
International Journal of Cancer|June 29, 2019
A case-control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic densityAdam R Brentnall, Elke M van Veen, Elaine F Harkness, et al.
Pageof 37